Home > News > Can Medical Nanotechnology Shorten Clinical Trials and Regulatory Pathways?
September 13th, 2005
Can Medical Nanotechnology Shorten Clinical Trials and Regulatory Pathways?
Nanotechnology is poised to enable advances that could be utilized to shave time and expense from multiple stages of the drug discovery and development efforts.
Ohio State University
National Cancer Institute
Doubling down on Schrödinger's cat May 27th, 2016
Harnessing solar and wind energy in one device could power the 'Internet of Things' May 26th, 2016
Thermal modification of wood and a complex study of its properties by magnetic resonance May 26th, 2016
Finding a new formula for concrete: Researchers look to bones and shells as blueprints for stronger, more durable concrete May 26th, 2016
Scientists illuminate a hidden regulator in gene transcription: New super-resolution technique visualizes important role of short-lived enzyme clusters May 27th, 2016
Supercrystals with new architecture can enhance drug synthesis May 24th, 2016
Nanoscale Trojan horses treat inflammation May 24th, 2016
Tiny packages may pack powerful treatment for brain tumors: Nanocarrier provides efficient delivery of chemotherapeutic drug May 23rd, 2016